MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-05-0002745
Iwave Pharmaceuticals Private Limited - chemicals in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹29.13 Lakh
▼ 39% YoY
Net profit · FY 2022
₹4.23 Lakh
Net margin 14.5%
EBITDA · FY 2022
₹11.08 Lakh
EBITDA margin 38%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Iwave Pharmaceuticals Private Limited
Data last updated:
Iwave Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2019PTC357403. Its GSTIN is 07AAFCI4652L1ZA (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanjay Gupta and Nikhil Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 6 Oberoi Appartments 2 Shamnath Marg Civil Lines, New Delhi, Delhi, India – 110054.
As per the financials filed for FY 2022, the company reported a revenue of ₹29.13 Lakh, a decline of 39% compared to the previous year. For the same year it recorded a net profit of ₹4.23 Lakh (net margin 14.5%) and EBITDA of ₹11.08 Lakh (EBITDA margin 38%).
Iwave Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0002745). For more details, the company can be reached via its website wavepharma.in.
Company Details of Iwave Pharmaceuticals Private Limited
CIN U24290DL2019PTC357403
Registration Number 357403
Incorporation Date 13 November 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-05-0002745
Recognitions & Rankings of Iwave Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressB – 6 Oberoi Appartments 2 Shamnath Marg Civil Lines, New Delhi, Delhi, India – 110054
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Iwave Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Iwave Pharmaceuticals Private Limited FY 2025 filings available
Iwave Pharmaceuticals Private Limited reported revenue of ₹29.13 Lakh (down 39% YoY) for FY 2022.
Revenue · FY 2022
₹29.13 Lakh ▼ 39%
Net profit · FY 2022
₹4.23 Lakh margin 14.5%
EBITDA · FY 2022
₹11.08 Lakh margin 38%
Compounded Annual Growth Rate (CAGR) of Iwave Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▼ 39%
EBITDA CAGR growth
1 year
▼ 68%
Revenue fell 39% in the latest year. EBITDA fell 68% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Iwave Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | ₹29.13 Lakh | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹11.08 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.23 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Iwave Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 38% | •••• | •••• |
| Net Profit Margin | 14.5% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Iwave Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Iwave Pharmaceuticals Private Limited
Iwave Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Gupta Also directs: Wave Pharmaceuticals Limited | Director | 13 Nov 2019 | 6 Years 11 Months | Current |
| Nikhil Gupta Also directs: Wave Pharmaceuticals Limited | Additional Director | 26 Nov 2025 | 0 Years 10 Months | Current |
Ownership and Shareholding of Iwave Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Iwave Pharmaceuticals Private Limited
Iwave Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Iwave Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Iwave Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Iwave Pharmaceuticals Private Limited
Iwave Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Nikhil Gupta was appointed as Additional Director on 26 Nov 2025.
Appointed
Nikhil Gupta was appointed as Additional Director.
AGM
Iwave Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Iwave Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Sanjay Gupta was appointed as Director.
Appointed
Sarita Gupta was appointed as Director.
Incorporation
13 Nov 2019
Iwave Pharmaceuticals Private Limited was registered on 13 Nov 2019 with Roc Delhi Ii & aged 6 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Iwave Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Iwave Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Iwave Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Iwave Pharmaceuticals Private Limited
Iwave Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCI4652L1ZA | Delhi | Active | 08 May 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Iwave Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Iwave Pharmaceuticals Private Limited
Iwave Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 November 2019 (7+ years old) and is registered under CIN U24290DL2019PTC357403.
Iwave Pharmaceuticals reported revenue of ₹29.13 Lakh for FY 2022 (down 39% YoY).
Iwave Pharmaceuticals has 2 current directors:
- Sanjay Gupta - Director
- Nikhil Gupta - Additional Director
Iwave Pharmaceuticals reported a net profit of ₹4.23 Lakh (net margin 14.5%) and EBITDA of ₹11.08 Lakh (EBITDA margin 38%) for FY 2022, as per its filed financial statements.
The GSTIN of Iwave Pharmaceuticals is 07AAFCI4652L1ZA, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Iwave Pharmaceuticals is U24290DL2019PTC357403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iwave Pharmaceuticals was incorporated on 13 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Nikhil Gupta was appointed as Additional Director on 26 Nov 2025. Sanjay Gupta was appointed as Director on 13 Nov 2019. Sarita Gupta was appointed as Director on 13 Nov 2019.
Yes, Iwave Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-05-0002745).
Iwave Pharmaceuticals can be reached through the website wavepharma.in. Its registered office is in New Delhi, Delhi, India.